Today's Low | Today's High | |
---|---|---|
62.97 62.20 |
| 66.52 66.38 |
52 Week Low | 52 Week High | |
---|---|---|
50.75 (12-Dec-2023) 51.00 (12-Dec-2023) |
| 91.87 (16-Sep-2024) 92.00 (16-Sep-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
0 | 12 |
Bid Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Ask Price | Quantity |
---|---|
64.72 | 12.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 12 |
Market Cap: | ₹1.05 Cr |
PE Ratio (TTM): | 199.57 |
PB Ratio: | 5.86 |
Industry P/E: | 198.04 |
Debt to Equity: | - |
ROE: | 2.94 |
EPS (TTM): | 0.33 |
Book Value: | 10.86 |
Face Value: | 10.00 |
Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
---|---|---|---|---|---|
Revenue | 17.37 Cr | 2.43 Cr | 13.62 Cr | 1.49 Cr | 2.62 Cr |
Profit | 0.12 Cr | 0.24 Cr | 0.21 Cr | 0.10 Cr | 0.05 Cr |
Expense | 17.25 Cr | 2.13 Cr | 13.33 Cr | 1.38 Cr | 2.58 Cr |
Comprehensive income | 0.12 Cr | 0.24 Cr | 0.11 Cr | 0.10 Cr | 0.05 Cr |
EPS | 0.08 | 0.15 | 0.07 | 0.06 | 0.03 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Biofil Chemicals & Pharmaceuticals Limited | Jun, 1996 Jan, 1994 | Pharmaceuticals Pharmaceuticals | BIOFILCHEM BIOFILCHEM |
Promoters | |
---|---|
46.82% |
Public | |
---|---|
53.18% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
46.82% |
Public | |
---|---|
53.18% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
46.82% |
Public | |
---|---|
53.18% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
46.82% |
Public | |
---|---|
53.18% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
46.82% |
Public | |
---|---|
53.18% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Today's stock performance witnessed a fluctuation from a minimum of 62.97 on the NSE (National Stock Exchange) to a maximum of 66.52. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 62.20 to a high of 66.38.
The stock's performance over the past 52 weeks reveals a low of 50.75 (occurred on 12-Dec-2023) and a high of 91.87 (achieved on 16-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 51.00 (on 12-Dec-2023), and the 52-week high is 92.00 (on 16-Sep-2024).
The stock's performance over the past 52 weeks reveals a low of 50.75 (occurred on 12-Dec-2023) and a high of 91.87 (achieved on 16-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 51.00 (on 12-Dec-2023), and the 52-week high is 92.00 (on 16-Sep-2024).
The total volume is 1, and the total traded value is 0.48 (₹ Lakhs).
The upper circuit limit is 78.22, and the lower circuit limit is 52.15.
The market cap is ₹1.05 Cr, and the PE ratio (TTM) is 198.04.
The PB ratio is 5.94, industry P/E is 198.04 .
ROE is 2.94, EPS is 0.33, book value is 10.86
In Sep 2023, Revenue is ₹173676000.00, and Profit is ₹1229000.00. In Jun 2023, Revenue is ₹24335000.00, and Profit is ₹2442000.00.
The company, Biofil Chemicals & Pharmaceuticals Limited, was listed in Jun 1996 and belongs to the Pharmaceuticals industry. Its NSE symbol is BIOFILCHEM.
As of latest available update, promoters hold 46.82%, the public holds 53.18%, and Employee Trusts holds 0.00.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.